GlassScriptPhysician profile
John D Parmely
NPI 1467442707
$44,208.23
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $13K · 2021: $9,440 · 2022: $21K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $43,310.39 | 2019-2022 | |
| Smith+Nephew, INC. | $247.27 | 2019 | |
| Tela Bio, INC. | $189.56 | 2019-2022 | |
| Polarityte, INC. | $188.58 | 2019 | |
| Depuy Synthes Sales INC. | $115.85 | 2021 | |
| Baudax Bio INC. | $107.04 | 2022 | |
| La Jolla Pharmaceutical Company | $25.30 | 2020 | |
| Ethicon US, LLC | $13.45 | 2020 | |
| Bard Peripheral Vascular, INC. | $10.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Parmely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.